UBS analysts upgrade Bank of America (BAC) to Buy from Neutral and lift their price target to $53 from $43. The analysts ...

Digital Realty shares rose 32% last year as demand for artificial intelligence capacity soared but data center space remained ...

As of now, UBS analysts expect Partners Group's performance fees to contribute between 20% and 30% of total revenues in 2024, ...

Financial analysts from HSBC and UBS upgrade Bank of America to Buy, citing favorable earnings outlook and stock valuation in ...

Fintel reports that on January 7, 2025, UBS initiated coverage of Tyra Biosciences (NasdaqGS:TYRA) with a Buy recommendation.

Shares in Computershare lowered in early trading on the ASX after UBS downgraded its rating on the share registry firm.

Mark Sullivan manages $800 million in client assets and is joining Procyon, while St. Petersburg, Fla.-based advisor Mary ...

UBS认为,在NASDAQ上市的Tyra Biosciences有潜力凭借其口服治疗方案引领市场。作为一种选择性FGFR3抑制剂,TYRA-300预计将比同时影响FGFR1、2和4的其他FGFR抑制剂提供更好的疗效和安全性。UBS分析师认为,TYRA-300在肿瘤学和生长障碍方面的长期机会比当前市场估值所反映的更为重要。

Authorities entered impeached President Yoon Suk Yeol's compound, evading a crowd of protesters outside, but were confronted ...

New York’s Bull Riding Team Set to Bring the Excitement of America’s Original Extreme Sport to a New Venue in September 2025 ...

UBS分析师使用了三年期反向折现现金流 (DCF)模型来支撑目标价。基于该模型，当前股价暗示2024年至2027年的收入复合年增长率 (CAGR)为9%，这与UBS预估的-1%收入CAGR形成对比。

Investing.com -- Shares of Boliden (ST: BOL) rose over 3% on Tuesday following an upgrade to a 'neutral' rating by analysts ...